Literature DB >> 4015182

Activation of complement by 405-nm light in serum from porphyria cutanea tarda.

W Torinuki, T Miura, H Tagami.   

Abstract

Sera from three patients with porphyria cutanea tarda (PCT) were examined for evidence of complement activation. The irradiation of sera in vitro with 405-nm light resulted in a dose-dependent diminution of total hemolytic complement activity and the hemolytic titers of C1, C4, C2, C3, and C5. Furthermore, such irradiated sera showed immunoelectrophoretical C3 conversion, chemotactic activity for rat polymorphonuclear leukocytes inhibited by incubation with anti-C5 antisera but not anti-C3 antisera, and C5a generation as measured by radioimmunoassay. Factor-B conversion did not occur in such irradiated sera. Using Sephadex G-75 chromatography, the irradiated sera showed a multiphasic elution profile of chemotactic activity similar to that of zymosan-activated serum. The generation of C5a even occurred in factor-B-depleted serum. These studies indicate that the irradiation of PCT serum with 405-nm light induces the activation of the complement system via the classical pathway, resulting in the development of a chemotactic factor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4015182     DOI: 10.1007/bf00404312

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  10 in total

1.  Plasma porphyrin concentrations in porphyria cutanea tarda.

Authors:  M R Moore; G G Thompson; B R Allen; J A Hunter; S Parker
Journal:  Clin Sci Mol Med       Date:  1973-11

2.  Interaction of porphyrins with proteins.

Authors:  P Koskelo; U Muller-Eberhard
Journal:  Semin Hematol       Date:  1977-04       Impact factor: 3.851

3.  Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.

Authors:  A Martin; P J Lachmann; L Halbwachs; M J Hobart
Journal:  Immunochemistry       Date:  1976-04

4.  Activation of complement in the skin after PUVA therapy.

Authors:  O J Clemmensen; B Staberg; A M Worm
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

5.  The complement system in necrotizing angiitis of the skin. Analysis of complement component activities in serum of patients with concomitant collagen-vascular diseases.

Authors:  N A Soter; K F Austen; I Gigli
Journal:  J Invest Dermatol       Date:  1974-08       Impact factor: 8.551

6.  Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda.

Authors:  H W Lim; H D Perez; M Poh-Fitzpatrick; I M Goldstein; I Gigli
Journal:  N Engl J Med       Date:  1981-01-22       Impact factor: 91.245

7.  Role of complement and polymorphonuclear cells in demethylchlortetracycline-induced phototoxicity in guinea pigs. Inhibition by decomplementation in vivo.

Authors:  H W Lim; H Novotny; I Gigli
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

8.  Role of complement in porphyrin-induced photosensitivity.

Authors:  H W Lim; I Gigli
Journal:  J Invest Dermatol       Date:  1981-01       Impact factor: 8.551

9.  Complement-derived chemotactic activity is generated in human serum containing uroporphyrin after irradiation with 405 nm light.

Authors:  H W Lim; H D Perez; I M Goldstein; I Gigli
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

10.  Activation of the alternative complement pathway by 405 nm light in serum from porphyric rat.

Authors:  W Torinuki; T Miura; H Tagami
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.